Clinical Trials in Salt Lake City

Showing 3941-3960 of 16,694 trials

A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants

NCT06615570

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of VX-973 in healthy participants.

Pain

Vertex Pharmaceuticals Incorporated30 participantsStarted Sep 2024

Salt Lake City, Utah, United States

Enrolling By Invitation< 1 mile

Genetic Factors Affecting Risks for Rotator Cuff Disease

NCT01193647

This study will begin to evaluate the heritability of rotator cuff disease, and begin creation of a powerful resource for future genetic studies of rotator cuff disease.

Studying the Genetic Relationship of Rotator Cuff Tears

University of Utah400 participantsStarted Jul 2009

Salt Lake City, Utah, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

NCT02752074

The purpose of the study is to assess the efficacy, safety, and tolerability when combining pembrolizumab with epacadostat or placebo in participants with unresectable or metastatic melanoma

Melanoma

Incyte Corporation706 participantsStarted Jun 2016

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +126 more locations

A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants

Genetic Factors Affecting Risks for Rotator Cuff Disease

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

Find Trials by Condition in Salt Lake City

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

Beating Heart Mitral Valve Repair With the HARPOON™ System

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

Study of JK07 in Patients With Chronic Heart Failure

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Study of Uterine Prolapse Procedures - Randomized Trial

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

Improving Mobility After Revascularization in Peripheral Artery Disease

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens